(Q37960818)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22116540%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

title

Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in cancer progression and survival: a systematic review (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22116540%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22116540%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

author name string

Liam J Murray

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22116540%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Marie M Cantwell

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22116540%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Carmel M Hughes

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22116540%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

publication date

25 November 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22116540%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

published in

Cancer Causes & Control

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22116540%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22116540%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22116540%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

221-230

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22116540%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10552-011-9881-x

17 January 2020

exact match

0 references

cites work

Angiotensin inhibition and malignancies: a review.

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9881-X

Angiotensin II activates extracellular signal regulated kinases via protein kinase C and epidermal growth factor receptor in breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9881-X

Role of host angiotensin II type 1 receptor in tumor angiogenesis and growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9881-X

Blockade of angiotensin AT1a receptor signaling reduces tumor growth, angiogenesis, and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9881-X

Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9881-X

Angiotensin-converting enzyme inhibitors and risk of esophageal and gastric cancer: a nested case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9881-X

Association between captopril, other antihypertensive drugs and risk of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9881-X

Association of ACE inhibitors and angiotensin receptor blockers with keratinocyte cancer prevention in the randomized VATTC trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9881-X

Angiotensin II receptor blockers and risk of cancer in patients with systemic hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9881-X

Angiotensin-converting enzyme inhibitors and the risk of cancer: a population-based cohort study in Denmark.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9881-X

Use of Angiotensin Receptor Blockers and the Risk of Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9881-X

Angiotensin receptor blockade and risk of cancer in type 2 diabetes mellitus: a nationwide case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9881-X

Angiotensin-receptor blockade and risk of cancer: meta-analysis of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9881-X

Effects of telmisartan, irbesartan, valsartan, candesartan, and losartan on cancers in 15 trials enrolling 138,769 individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9881-X

Angiotensin receptors: a new role in cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9881-X

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9881-X

Examining the influence of beta blockers and ACE inhibitors on the risk for breast cancer recurrence: results from the LACE cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9881-X

Angiotensin system inhibitors and outcome of sunitinib treatment in patients with metastatic renal cell carcinoma: a retrospective examination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9881-X

Beta-blocker use is associated with improved relapse-free survival in patients with triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9881-X

Inhibition of renin-angiotensin system affects prognosis of advanced pancreatic cancer receiving gemcitabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9881-X

Combination of vitamin K2 and angiotensin-converting enzyme inhibitor ameliorates cumulative recurrence of hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9881-X

Angiotensin converting enzyme inhibitors for cancer treatment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9881-X

Potential role of Renin-Angiotensin-system for tumor angiogenesis in receptor negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9881-X

Performance status score: do patients and their oncologists agree?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9881-X

Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9881-X

Weight, physical activity, diet, and prognosis in breast and gynecologic cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9881-X

Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9881-X

Angiotensin-Converting Enzyme Inhibitors, Calcium Channel Blockers, and Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9881-X

10.1007/S10552-011-9881-X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22116540%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference